Identifying New Susceptibility Genes of Non-Syndromic Orofacial Cleft Based on Syndromes Accompanied With Craniosynostosis

Abstract

Objectives

Orofacial cleft (OC) can be classified into syndromic orofacial cleft (SOC) and non-syndromic orofacial cleft (NSOC), depending on whether there are other congenital deformities. Craniosynostosis, the premature closure of cranial sutures, is a common phenotype of SOC resulting in abnormal ossification of skull and brain development disorders. Its correlation with OC offers a promising approach to identify susceptibility genes for NSOC by examining causative genes of SOCs with craniosynostosis.

Materials and Methods

This study included 2556 patients with NSOC and 2255 normal controls from western Han Chinese with their genomic DNA samples. We selected 31 causative genes of 34 syndromes with both craniosynostosis and OC as candidate genes and performed quality control. Allelic and genotypic association analyses and haplotype analysis were performed to identify statistically significant single nucleotide polymorphisms (SNPs).

Results

In allelic association analysis performed with 1265 qualified SNPs in 20 genes, only rs2239936, located in MYH3 gene, was statistically associated with non-syndromic cleft lip only (NSCLO) (P = 1.70×10⁻⁰⁷, OR = 1.33, 95%CI: 1.17-1.52) and non-syndromic cleft palate only (NSCPO) (P = 6.43×10⁻⁰⁵, OR = 1.33, 95%CI: 1.16-1.52). The higher frequency of allele G in NSCPO suggesting that minor allele G at rs2239936 will result in an elevated risk of NSCPO. However, rs2239936 only exhibited a statistical association with NSCPO in genotypic association analysis (P = 8.06×10⁻⁰⁶) and haplotype analysis (P = 1.43×10⁻⁰⁵).

Conclusion

This study identified that allele G at rs2239936 in MYH3 gene was significantly associated with NSCPO as a risk factor and MYH3 was a new susceptibility gene for NSCPO in western Han Chinese population.

Keywords

non-syndromic orofacial cleft syndromic orofacial cleft craniosynostosis

Get full access to this article

View all access options for this article.

References

Rahimov

Jugessur

Murray

. Genetics of nonsyndromic orofacial clefts. Cleft Palate Craniofac J. 2012;49(1):73–91. doi:https://doi.org/10.1597/10-178

Stock

Costa

Wilkinson-Bell

Culshaw

Kearney

Edwards

. Psychological and physical health outcomes in adults with craniosynostosis. Cleft Palate Craniofac J. 2023;60(3):257–267. doi:https://doi.org/10.1177/10556656211059966

Malic

Lam

Donelle

Richard

Vigod

Benchimol

. The burden of psychiatric disorders associated with orofacial cleft pathology among children in Ontario, Canada. J Plast Reconstr Aesthet Surg. 2023;84:422–431. doi:https://doi.org/10.1016/j.bjps.2023.06.019

Alois

Ruotolo

. An overview of cleft lip and palate. Jaapa. 2020;33(12):17–20. doi:https://doi.org/10.1097/01.Jaa.0000721644.06681.06

Fan

Liu

, et al. Prevalence of non-syndromic orofacial clefts: Based on 15,094,978 Chinese perinatal infants. Oncotarget. 2018;9(17):13981–13990. doi:https://doi.org/10.18632/oncotarget.24238

Martin

Swan

. An essential overview of orofacial clefting. Br Dent J. 2023;234(12):937–942. doi:https://doi.org/10.1038/s41415-023-6000-9

Leslie

Marazita

. Genetics of cleft lip and cleft palate. Am J Med Genet C Semin Med Genet. 2013;163c(4):246–258. doi:https://doi.org/10.1002/ajmg.c.31381

Hazelett

Conti

Han

, et al. Reducing GWAS complexity. Cell Cycle. 2016;15(1):22–24. doi:https://doi.org/10.1080/15384101.2015.1120928

Tam

Patel

Turcotte

Bossé

Paré

Meyre

. Benefits and limitations of genome-wide association studies. Nat Rev Genet. 2019;20(8):467–484. doi:https://doi.org/10.1038/s41576-019-0127-1

10.

Suzuki

Bustos

, et al. Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia. Nat Genet. 2000;25(4):427–430. doi:https://doi.org/10.1038/78119

11.

Sözen

Suzuki

Tolarova

Bustos

Fernández Iglesias

Spritz

. Mutation of PVRL1 is associated with sporadic, non-syndromic cleft lip/palate in northern Venezuela. Nat Genet. 2001;29(2):141–142. doi:https://doi.org/10.1038/ng740

12.

Stanier

Moore

. Genetics of cleft lip and palate: Syndromic genes contribute to the incidence of non-syndromic clefts. Hum Mol Genet. 2004;13(Spec No 1):R73–R81. doi:https://doi.org/10.1093/hmg/ddh052

13.

Dempsey

Monson

Maricevich

, et al. Nonsyndromic craniosynostosis. Clin Plast Surg. 2019;46(2):123–139. doi:https://doi.org/10.1016/j.cps.2018.11.001

14.

Sawh-Martinez

Steinbacher

. Syndromic craniosynostosis. Clin Plast Surg. 2019;46(2):141–155. doi:https://doi.org/10.1016/j.cps.2018.11.009

15.

Willie

Holmes

Jabs

. Cleft palate in Apert syndrome. J Dev Biol. 2022;10(3):33. doi:https://doi.org/10.3390/jdb10030033

16.

Leslie

Taub

Liu

, et al. Identification of functional variants for cleft lip with or without cleft palate in or near PAX7, FGFR2, and NOG by targeted sequencing of GWAS loci. Am J Hum Genet. 2015;96(3):397–411. doi:https://doi.org/10.1016/j.ajhg.2015.01.004

17.

Lin

Shi

Jia

. Integrating transcriptomics and genomics to identify fibroblast growth factor/receptor candidate genes for non-syndromic orofacial cleft in Chinese. Arch Oral Biol. 2023;153:105750. doi:https://doi.org/10.1016/j.archoralbio.2023.105750

18.

Zhang

Shen

Xing

, et al. MiR-106a-5p modulates apoptosis and metabonomics changes by TGF-β/Smad signaling pathway in cleft palate. Exp Cell Res. 2020;386(2):111734. doi:https://doi.org/10.1016/j.yexcr.2019.111734

19.

Nakajima

Shuler

Gulka

AOD

Hanai

JI.

TGF-β signaling and the epithelial-mesenchymal transition during palatal fusion. Int J Mol Sci. 2018;19(11):3638. doi:https://doi.org/10.3390/ijms19113638

20.

Barik

Bajpai

Malhotra

Samantaray

Dwivedi

Das

. Genome-Wide association study in craniosynostosis condition using innovative systematic bioinformatic analysis tools and techniques: Future prospective and clinical practice. J Pediatr Neurosci. 2018;13(2):170–175. doi:https://doi.org/10.4103/jpn.JPN_71_17

21.

Boyadjiev

. Genetic analysis of non-syndromic craniosynostosis. Orthod Craniofac Res. 2007;10(3):129–137. doi:https://doi.org/10.1111/j.1601-6343.2007.00393.x

22.

Huang

Jia

Shi

, et al. Genetic factors define CPO and CLO subtypes of nonsyndromicorofacial cleft. PLoS Genet. 2019;15(10):e1008357. doi:https://doi.org/10.1371/journal.pgen.1008357

23.

Sun

Huang

Yin

, et al. Genome-wide association study identifies a new susceptibility locus for cleft lip with or without a cleft palate. Nat Commun. 2015;6:6414. doi:https://doi.org/10.1038/ncomms7414

24.

Kajdic

Spazzapan

Velnar

. Craniosynostosis - recognition, clinical characteristics, and treatment. Bosn J Basic Med Sci. 2018;18(2):110–116. doi:https://doi.org/10.17305/bjbms.2017.2083

25.

Tønne

Due-Tønnessen

Wiig

, et al. Epidemiology of craniosynostosis in Norway. J Neurosurg Pediatr. 2020;26(1):68–75. doi:https://doi.org/10.3171/2020.1.Peds2051

26.

Blessing

Gallagher

. Epidemiology, genetics, and pathophysiology of craniosynostosis. Oral Maxillofac Surg Clin North Am. 2022;34(3):341–352. doi:https://doi.org/10.1016/j.coms.2022.02.001

27.

Carlson

Taub

Feingold

, et al. Identifying genetic sources of phenotypic heterogeneity in orofacial clefts by targeted sequencing. Birth Defects Res. 2017;109(13):1030–1038. doi:https://doi.org/10.1002/bdr2.23605

28.

Dong

Zhang

Lai

, et al. Dura cells in the etiopathogenesis of crouzon syndrome: The effects of FGFR2 mutations in the dura cells on the proliferation of osteoblasts through the hippo/YAP mediated transcriptional regulation pathway. Am J Transl Res. 2021;13(10):11255–11270.

29.

Wang

Zhang

, et al. The FGF and FGFR gene family and risk of cleft lip with or without cleft palate. Cleft Palate Craniofac J. 2013;50(1):96–103. doi:https://doi.org/10.1597/11-132

30.

Jiang

Shim

Zhang

Cao

. Bone morphogenetic protein is required for fibroblast growth factor 2-dependent later-stage osteoblastic differentiation in cranial suture cells. Int J Clin Exp Pathol. 2015;8(3):2946–2954.

31.

Agarwal

Sharma

Kumar

, et al. Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. Development. 2020;147(7):dev184507. doi:https://doi.org/10.1242/dev.184507

32.

Cameron-Christie

Wells

Simon

, et al. Recessive spondylocarpotarsal synostosis syndrome due to compound heterozygosity for variants in MYH3. Am J Hum Genet. 2019;105(3):669. doi:https://doi.org/10.1016/j.ajhg.2019.08.007

33.

Das

Kumar

Verma

Maiti

Mathew

. Myosin heavy chain mutations that cause Freeman-Sheldon syndrome lead to muscle structural and functional defects in Drosophila. Dev Biol. 2019;449(2):90–98. doi:https://doi.org/10.1016/j.ydbio.2019.02.017

34.

Zieba

Zhang

Chong

, et al. A postnatal role for embryonic myosin revealed by MYH3 mutations that alter TGFβ signaling and cause autosomal dominant spondylocarpotarsal synostosis. Sci Rep. 2017;7:41803. doi:https://doi.org/10.1038/srep41803

35.

Carapito

Goldenberg

Paul

, et al. Protein-altering MYH3 variants are associated with a spectrum of phenotypes extending to spondylocarpotarsal synostosis syndrome. Eur J Hum Genet. 2016;24(12):1746–1751. doi:https://doi.org/10.1038/ejhg.2016.84

36.

Vaiman

Fritz

Beauvallet

, et al. Mutation of the MYH3 gene causes recessive cleft palate in Limousine cattle. Genet Sel Evol. 2022;54(1):71. doi:https://doi.org/10.1186/s12711-022-00762-2

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB

0.02 MB